We have investigated, in isolated, perfused, spontaneously beating guinea pig hearts, the influence of perfusate pH on the coronary vasodilation produced by exogenous adenosine and on the inhibition of adenosine vasodilation by theophylline. Perfusate pH 7.20 and 6.89, produced by increasing Pco 2 , reduced the concentration at which adenosine produced a response. Furthermore, the flow increment in response to higher adenosine concentrations was greater at pH 6.89 and less at pH 7.69 than at pH 7.42. The flow responses to alterations in pH was greater in the presence of adenosine (5 x 10 7 M) than in its absence. Theophylline, in amounts which by themselves were without effect on coronary flow, partially inhibited coronary vasodilation caused by adenosine both at pH 7.43 and 7.20. Our findings indicate that the coronary vasodilation produced by adenosine is pH sensitive but attenuation of this dilation by theophylline is not, at the values of pH tested. We conclude that theophylline's inability to regularly attenuate reactive hyperemia might be related to enhanced adenosine dilation caused by increased tissue hydrogen ion activity. Furthermore, the hydrogen ion might participate in coronary flow regulation in part via this interaction with adenosine.
different proportions of O 2 and CO 2 . Samples of freshly prepared stock solutions of adenosine or theophylline (Sigma Chemical Co.) were added to the perfusate to give the desired concentrations.
Aortic inflow, equal to total coronary flow, was monitored with an electromagnetic flowmeter (Biotronex BL-610); the extracorporeal flow probe was interposed in the perfusion circuit 2-3 cm above the isolated heart.
At the start of all experiments, heart rate and coronary flow were allowed to stabilize for 20-30 minutes. When adenosine or theophylline was studied, a period of approximately 10 minutes was allowed for each concentration to produce its maximal effect. Coronary flow (phasic and mean) and heart rate were recorded at each concentration.
Stepwise changes in the pH of the perfusate were made by switching the perfusion to a previously prepared reservoir.
Data variability initially was evaluated using a ramdomized complete blocks analysis of variance. Means were subsequently compared by Tukey's tv-procedure.
Results
Dose-Responses to Adenosine (lO^-lO" 6 M) at pH 7.42, 7.36, 7.20, 6.89, and 7. 69 The effects of adenosine on coronary flow and heart rate were determined at a perfusate pH of 7.42, and then the perfusate was switched to one of a different pH and the dose-response to adenosine was repeated. Each change of pH from 7.42 was tested in a separate series of hearts. Table 1 shows that reducing the pH to 7.36 had little effect on the relationship between adenosine concentration and coronary flow (n = 9). However, at pH 7.20 (n = 9) and pH 6.89 (n = 6), the adenosine concentration at which significant dilation occurred was lower than at pH 7.42. Table 1 and Figure 1 show that this effect was also observed when the dose-response relationship for adenosine at pH 7.20 was evaluated before the dose- response at pH 7.42 (n = 8 ) . Furthermore, the increase in flow was greater at pH 6.89 (n = 6) and smaller at pH 7.69 (n = 8) than at pH 7.42. Heart rate was only occasionally affected. heart the effects on flow of changing pH alone were studied first. Perfusate pH was then returned to 7.42 and flow was allowed to stabilize. Adenosine was added to the perfusate and the pH was altered again. In three hearts the sequence of changes in pH was fixed; in the other four it was randomized. Data from all seven are presented together, since the sequence of perfusion had no influence on the results. In the absence of adenosine, i"5 8
Effect of Perfusate pH on Coronary Flow in the
Theophylline CM] pH 7.69 produced no significant effect on coronary flow, while pH 6.89 increased flow 2.8 ml/min above control (pH 7.42). In the presence of adenosine, pH 7.69 significantly reduced flow by 1.7 ml/min and pH 6.89 increased flow by 10 ml/min relative to control (pH 7.42); thus the response to perfusate pH was much greater in the presence of adenosine than in its absence, even though at a low pH the vascular bed already was partially dilated. Spontaneous heart rate was not influenced.
Dose-Responses to Theophylline at pH 7.43 and 7.20 Figure 3 illustrates the effects of theophylline on coronary flow and spontaneous heart rate. Figure 3A shows that neither variable was significantly affected by theophylline at either pH 7.43 or 7.20 (n = 6). However, at concentrations greater than 10~4 M (Fig. 3B ), both variables were markedly elevated (n = 5). In the first group of six hearts (at pH 7.43), 5 x 10~5 M theophylline produced little effect on the magnitude or duration of hyperemia following release of a 30-second occlusion ( Table 2) . When adenosine dilation (8 x 10~7 M) was challenged by theophylline (10-|! -10-4 M), first at pH 7.43 and then at 7.20, significant attenuation was observed with 10" 4 M theophylline at both levels of pH (Fig. 4A ). Although the average reduction in flow was somewhat less at pH 7.20, it was not significantly different from the reduction seen at 7.43. When the perfusion sequence was reversed, qualitatively similar but quantitatively different results were obtained (Fig. 4B ). Adenosine (8 x 10~7 M) increased flow from 6.6 ± 0.31 to 14.2 ± 0.96 ml/min at pH 7.20. Theophylline (10~4 M) reduced the maximal response to 9.9 ± 0.51 ml/min. When hearts were switched to pH 7.42, the same concentration of adenosine increased flow to a lesser degree (from 5.4 ± 0.42 to 9.5 ± 0.61 ml/min). Theophylline (10~4 M) now did not significantly influence this response.
Time Course of Coronary Flow Response to Adenosine (8 x 10" 7 M) at pH 7.20
Attenuation of adenosine-induced dilation by theophylline must be distinguished from time-dependent diminution of adenosine dilation. Table 3 shows that, at pH Flow rates are compared to control flow and to the flow at the 5th minute following the addition of adenosine. Heart rate was not affected. These data indicate that theophylline-induced attenuation of adenosine dilation (Fig. 4) was not influenced by a waning of the response to adenosine.
Discussion
Failure of the methyl xanthines to attenuate coronary reactive and hypoxic hyperemias while successfully inhibiting coronary responses to exogenous adenosine 1 " 5 ' "• 9 has hindered general acceptance of the adenosine hypothesis'*" 12 for coronary blood flow regulation. We have considered several explanations for this apparent paradox. One possibility is that the concentrations of adenosine in the vicinity of the arteriole during ischemia and hypoxia exceed those which can be inhibited significantly by 10~4 M theophylline, the maximum amount that can be given to the heart without side effects. Some indirect support for this possibility comes from the work of Biinger et al. 1 who demonstrated reversible competition between theophylline and adenosine in the coronary vasculature of isolated, perfused guinea pig hearts. Competition was incomplete however; 5 x 10~7 M adenosine, a concentration which produced 75% maximal dilation, was only slightly more than half inhibited by 5.5 x 10~5 M theophylline, while 10~6 adenosine, a concentration that produced 85% maximal dilation, was only 25% inhibited by 5.5 x 10~5 M theophylline. Incomplete inhibition was also demonstrated in the present study ( Fig. 4) . Concentrations of adenosine as high as 8.8 x 10~8 M have been observed in the effluent of this preparation during hypoxic hyperemia, 13 and 6.4 x 10~8 M adenosine has been found in the pericardial perfusate of open-chest dogs during stellate ganglion stimulation. 14 It seems likely that concentrations exceed this value at the arteriole, particularly during global ischemia. The response of a bioassay organ (isolated, denervated kidney) to coronary sinus blood during cardiac ischemia or hypoxia can be completely blocked by theophylline. 15 Here, however, one can apply theophylline in concentrations as high as 10" 3 M. Thus the possibility exists that adenosine concentrations at the arteriole exceed those which can be substantially inhibited by the concentration of theophylline that can be given to the heart without changes in rate.
On the other hand, there are reasons to believe that mechanisms other than strict adenosine-theophylline competition are operative in the failure of theophylline to block reactive hyperemia, hypoxic hyperemia, and autoregulation in the heart. Raberger and associates 1 " reported a direct correlation between the magnitude of response of the coronary circulation to an intracoronary bolus of adenosine (1-7 /ag/kg) and the hydrogen ion activity of systemic blood in the thoracotomized dog. Raberger et al. 17 more recently reported enhanced reactive hyperemia during hypercapnic acidosis in thoracotomized dogs. It is established that venous effluent and myocardial tissue levels of adenosine, inosine, and hypoxanthine increase during myocardial reactive hyperemia 12 ' '*• 1!l and during elevated cardiac metabolic activity. 14 Since coronary effluent pH also decreases during cardiac ischemia, 2 "-21 it seems plausible that simultaneously released adenosine and hydrogen ions interact to produce coronary dilation.
In the current study we examined certain pH-adenosinetheophylline interactions which might account for theophylline's failure to block reactive and hypoxic coronary hyperemia. We used the isolated heart preparation to avoid neurohumoral interference. Our results demonstrate that modest lowering of perfusate pH from 7.42 to 7.36 has no effect on the coronary dilation produced by adenosine. However, further reduction in pH to 7.20 and 6.89 significantly decreases the threshold concentration for adenosine vasodilation, and this is independent of the perfusion sequence in the case of pH 7.20. Furthermore, at pH 6.89, the increment in flow produced by 5 x 10~7 M adenosine exceeds that at pH 7.42, despite the fact that the vascular bed initially is partially dilated. These findings indicate that high Pco 2 enhances the dilating ability of adenosine in this preparation. Consistent with this interpretation is the observation that decreased perfusate Pco 2 retards adenosine dilation, despite a higher initial resistance to coronary flow. At pH 7.42, control flow was 6.2 ml/min, and 5 x 10~7 M adenosine increased flow to 12.8 ml/min, an increment of 6.4 ml/min. At pH 7.69, however, this same concentration of adenosine increased flow to 8.6 ml/min, an increment of only 2.8 ml/min. The cellular mechanism of this effect is not clear; whatever the mechanism, it probably operates at the cell surface, because there now is good evidence that adenosine dilates even when firmly attached to molecules that cannot penetrate into the coronary myocyte. 22 -211 The reverse was also clearly demonstrated, namely, the increases in coronary flow produced by increasing the hydrogen ion concentration were greater in the presence of adenosine. Decreasing pH from 7.43 to 6.89 produced only a modest increase in flow in the absence of adenosine. However, in the presence of 5 x 10~7 M adenosine, the increase in flow was much larger, despite the fact that the coronary bed was initially slightly dilated. Increasing pH from 7.43 to 7.69 had no significant effect on flow in the absence of adenosine.
Finally, this study failed to show that the competitive inhibition of adenosine vasodilation by theophylline is sensitive to moderate hypercapnic acidosis. Theophylline, 10~" to 10~4 M, by itself had no effect on coronary flow or spontaneous heart rate at either pH 7.43 or pH 7.20. When superimposed on adenosine, 8 x 10~7 M, inhibition by theophylline was essentially the same at pH 7.43 and 7.20. Inhibition was also observed at pH 7.20 when the perfusion sequence was reversed. Our results do not allow extension of this conclusion to more severe hypercapnic acidosis.
Findings from this study therefore suggest that the failure of theophylline to block coronary reactive hyperemia, again demonstrated herein, is at least in part related to an enhancement of adenosine's dilating ability by increased hydrogen ion concentration. Our results also suggest that increased hydrogen ion activity may participate in local regulation of coronary blood flow both directly and indirectly, in the case of the latter, by altering the vasoactivity of adenosine.
